Filing Details
- Accession Number:
- 0001437749-18-011846
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-14 17:06:14
- Reporting Period:
- 2018-05-16
- Accepted Time:
- 2018-06-14 17:06:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1029125 | Sun Biopharma Inc. | SNBP | Pharmaceutical Preparations (2834) | 870543922 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652797 | W. Paul Schaffer | 712 Vista Blvd #305 Waconia MN 55387 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-16 | 5,000 | $0.00 | 899,204 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-05-16 | 11,756 | $0.00 | 200,848 | No | 4 | C | Indirect | By Paul W. Schaffer Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | C | Indirect | By Paul W. Schaffer Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Acquisiton | 2018-05-16 | 5,000 | $0.00 | 5,000 | $5.00 |
| Common Stock | Convertible Promissory Note | Disposition | 2018-05-16 | 50,000 | $50,000.00 | 4,950 | $10.10 |
| Common Stock | Warrant (right to buy) | Acquisiton | 2018-05-16 | 11,756 | $0.00 | 11,756 | $5.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,000 | 2018-05-16 | 2021-05-16 | No | 4 | P | Direct |
| 0 | 2017-03-17 | 2018-12-01 | No | 4 | C | Indirect |
| 11,756 | 2018-05-16 | 2021-05-16 | No | 4 | C | Indirect |
Footnotes
- Reflects purchase of 5,000 units from the issuer at a price equal to $5.00 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
- Pursuant to the "alternate conversion" under the Convertible Promissory Note, approximately $52,902 of outstanding principal and accrued but unpaid interest converted into 11,756 units at a price equal to $4.50 per unit. Each unit consisted of one share of common stock and a warrant to purchase an additional share of common stock.
- Originally convertible into issuer common stock at a price of $10.10 per share upon holder's election. Because a "qualified offering" occurred, outstanding principal and accrued but unpaid interest would have automatically converted into common stock at a rate of $3.35 per share or, as elected, into units at a rate equal to a 10% discount to the price paid in the qualified offering.
- Represents original principal amount.
Billionaire Hedge Funds
